Appili Therapeutics

Appili Therapeutics was founded in 2015 by a team of experts in drug development, infectious diseases, and commercialization to advance the global fight against infectious diseases and drug-resistant pathogens. Our approach is to match unmet medical needs with opportunities for more effective solutions, ranging from improved established therapies to entirely new classes of anti-infective drugs.Appili fosters a culture of listening: to the needs of patients, healthcare practitioners, researchers, employees, and shareholders. Through this culture, we are identifying clinical needs that competitors overlook or ignore, creating products that resonate with healthcare practitioners and payers, cultivating motivated employees to deliver these products, and generating the potential for substantial returns for our shareholders.